NASDAQ: QNTM
Quantum Biopharma Ltd Stock Ownership - Who owns Quantum Biopharma?

Insider buying vs selling

Have Quantum Biopharma Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when QNTM insiders and whales buy or sell their stock.

QNTM Shareholders

What type of owners hold Quantum Biopharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Advisorshares Investments LLC0.98%37,237$366.41kInstitution
Marex Group PLC0.35%13,436$132.21kInstitution
Ubs Group Ag0.23%8,754$86.14kInstitution
Steward Partners Investment Advisory LLC0.08%3,100$30.50kInstitution
Morgan Stanley0.07%2,564$25.23kInstitution
Jpmorgan Chase Co0.02%736$7.24kInstitution
Osaic Holdings Inc0.02%680$6.69kInstitution
Royal Bank Of Canada0.02%583$5.74kInstitution
Cetera Trust Company Na0.01%250$2.46kInstitution
Sbi Securities Co Ltd0.00%155$1.53kInstitution

1 of 2

QNTM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
QNTM1.78%0.00%
RMTI8.46%91.54%Net SellingNet Selling
CPIX22.78%55.91%Net BuyingNet Buying
BGM3.99%0.00%
SCYX28.05%21.55%Net BuyingNet Buying

Quantum Biopharma Stock Ownership FAQ

Who owns Quantum Biopharma?

Quantum Biopharma (NASDAQ: QNTM) is owned by 1.78% institutional shareholders, 0.00% Quantum Biopharma insiders, and 98.22% retail investors. Advisorshares Investments LLC is the largest individual Quantum Biopharma shareholder, owning 37,237.00 shares representing 0.98% of the company. Advisorshares Investments LLC's Quantum Biopharma shares are currently valued at $349.28k.

If you're new to stock investing, here's how to buy Quantum Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.